Could cause temporary or reversible harm; serious harm is unlikely.
Subpotent Drug: During routine stability testing one tablet was found with tablet weight below specification.
| Distributed by / for | Actavis Elizabeth LLC |
| NDC | 0228-3005-11 |
| Full product label | Clonazepam Tablets, USP 2 mg 100 tablets Manufactured by: Actavis Elizabeth LLC 200 Elmora Avenue, Elizabeth, NJ 0737 USA NDC 0228-3005-11 packaged in White/Round HDPE 75 CC with white/round plastic 33 mm CRC closure shipped in corrugated 75 cc carton (24 bottles/carton) |
| Recalling firm | Actavis Elizabeth LLC |
| Distribution | Nationwide |
| Quantity | 13,608 bottles |
| Recall initiated | 2013-11-06 |
| Report date | 2014-03-05 |
| Recall completed | 2014-06-02 |
| Recall number | D-1087-2014 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Elizabeth NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗